Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Myofibrillar myopathy and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Myofibrillar myopathy and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Myofibrillar myopathy and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 208 | 81 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Myofibrillar myopathy and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Myofibrillar myopathy and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Myofibrillar myopathy and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 19 | 11 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 183 | 142 |
|
Invitae Cardiomyopathy Comprehensive Panel Invitae United States | 198 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 239 | 100 |
|
Invitae Hypertrophic Cardiomyopathy Panel Invitae United States | 69 | 30 |
|
FHL1-Myopathies via the FHL1 Gene PreventionGenetics, part of Exact Sciences United States | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.